GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit
www.grail.com.
Are you a Sr Scientist interested in working on Multi-Cancer Early detection products?
Grail is seeking a Senior Process Engineer to develop reagents for use in Multi-Cancer Early Detection products. In this position, the person will work closely with the R&D team(s) to demonstrate feasibility, generate product specifications, develop robust manufacturing & QC processes, establish shelf life, & transfer processes to manufacturing. The Senior Process Engineer will develop reagent formulation processes & analytical quality control protocols, & will develop strategies for formulation optimization & reagent manufacturing development. They will provide technical expertise to the new product introduction & will characterize reagents to meet product requirements. Candidates should have strong hands-on laboratory experience, including reagent formulations, analytical assay development & reagent manufacturing.
